Search Results

Suven Life Sciences informs about press release.

Subjects: PRESS releases; CATAPLEXYSUVEN Life Sciences Ltd.

• Source: Ace Analyser: Company News; 9/24/2019, pN.PAG-N.PAG, 1p

Record details

Decisions Update.

Subjects: *PHARMACEUTICAL industry; CHRONIC lymphocytic leukemia; DRUG marketingBIOGEN Inc. (2003- ) BIOGEN Inc. (2003- ) BIOGEN Inc. (2003- ) BIIB; UNITED States. Food & Drug Administration ; EUROPEAN Medicines Agency

• Source: PharmaWatch: Biotechnology. Mar2007, Vol. 6 Issue 3, p10-11. 2p.

Record details

Orexo receives regulatory approval for insomnia drug in Europe.

Subjects: DRUG approval; INSOMNIA treatment; ZOLPIDEMEUROPEOREXO AB

• Source: PharmaWatch: CNS. Aug2012, Vol. 11 Issue 8, p12-13. 2p.

Record details

Sleep and Fatigue Update.

Subjects: SLEEP disorders; FATIGUE (Physiology); NARCOLEPSYUNITED StatesJAZZ Pharmaceuticals Inc. ; TEVA Pharmaceutical Industries Ltd. ; CEPHALON Inc. 183236314 CEPHALON Inc. CEPHALON Inc. 183236314 183236314 CEPHALON Inc. 183236314 CEPH

• Source: PharmaWatch: CNS. Jan2006, Vol. 5 Issue 1, p7-8. 2p.

Record details

Trial success for Orphan Medical narcolepsy drug.

Subjects: CLINICAL trials; THERAPEUTICS; NARCOLEPSYORPHAN Medical Inc. 847412871 ORPHAN Medical Inc. ORPHAN Medical Inc. 847412871 847412871 ORPHAN Medical Inc. 847412871 ORPH

• Source: PharmaWatch: CNS. November 2004, Vol. 3 Issue 11, p6-7. 2p.

Record details

The Midlife Crisis.

• Authors : Giuntella, Osea; McManus, Sally; Mujcic, Redzo

• Source: NBER Working Papers; Sep2022, Issue 30411-30504, p2-73, 71p

Record details

NARCOLEPSY.

• Authors : Simon, Harvey; Zieve, David

Subjects: NARCOLEPSY; SLEEP disorders; ETIOLOGY of diseases

• Source: Narcolepsy (A.D.A.M.); 5/29/2008, p1-7, 7p, 1 Chart

Record details

NARCOLEPSY.

• Authors : Simon, Harvey

Subjects: NARCOLEPSY; DROWSINESS; MUSCLE tone

• Source: Narcolepsy (A.D.A.M.); 8/3/2007, p1-8, 8p, 1 Chart

Record details

Improving Sleep: A guide to a good night's rest.

Subjects: RAPID eye movement sleep; SLEEP deprivation; INSOMNIA

• Source: Improving Sleep: A Guide to a Good Night's Rest (2019); 2019, p1-53, 57p

Record details

Suven declares dose administration of 1st patient in Phase 2A clinical trial of SUVN G-3031.

Subjects: CLINICAL trials; NEUROSCIENCES; ADMINISTRATIVE lawUNITED StatesSUVEN Life Sciences Ltd.

• Source: Ace Analyser: Company News; 9/25/2019, pN.PAG-N.PAG, 1p

Record details